SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-061077
Filing Date
2021-02-26
Accepted
2021-02-26 17:28:18
Documents
18
Period of Report
2021-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d480193d8k.htm   iXBRL 8-K 33478
2 EX-5.1 d480193dex51.htm EX-5.1 8292
3 EX-10.2 d480193dex102.htm EX-10.2 17405
7 GRAPHIC g480193img001.jpg GRAPHIC 4868
8 GRAPHIC g480193img002.jpg GRAPHIC 4056
9 GRAPHIC g480193img004.jpg GRAPHIC 826
10 GRAPHIC g480193img005.jpg GRAPHIC 2456
  Complete submission text file 0001193125-21-061077.txt   205706

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA reph-20210226.xsd EX-101.SCH 3078
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20210226_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20210226_pre.xml EX-101.PRE 10958
11 EXTRACTED XBRL INSTANCE DOCUMENT d480193d8k_htm.xml XML 3211
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 21691540
SIC: 2834 Pharmaceutical Preparations